Donaldson Capital Management, LLC Novo Nordisk A S Transaction History

Donaldson Capital Management, LLC

  • $2.59 Billion
  • Q3 2024

A detailed history of Donaldson Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 30,961 shares of NVO stock, worth $3.26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
30,961
Previous 31,927 3.03%
Holding current value
$3.26 Million
Previous $4.56 Million 19.11%
% of portfolio
0.14%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$119.07 - $145.42 $115,021 - $140,475
-966 Reduced 3.03%
30,961 $3.69 Million
Q2 2024

Jul 31, 2024
SELL
$122.71 - $146.91 $86,142 - $103,130
-702 Reduced 2.15%
31,927 $4.56 Million
Q1 2024

Apr 22, 2024
BUY
$102.11 - $135.92 $1,531 - $2,038
15 Added 0.05%
32,629 $4.19 Million
Q4 2023

Jan 30, 2024
SELL
$87.78 - $105.45 $247,978 - $297,896
-2,825 Reduced 7.97%
32,614 $3.37 Million
Q3 2023

Oct 11, 2023
BUY
$90.94 - $199.54 $1.54 Million - $3.38 Million
16,927 Added 91.44%
35,439 $3.22 Million
Q2 2023

Jul 17, 2023
SELL
$155.98 - $172.65 $204,801 - $226,689
-1,313 Reduced 6.62%
18,512 $3 Million
Q4 2022

Feb 08, 2023
BUY
$102.55 - $135.33 $22,971 - $30,313
224 Added 1.14%
19,825 $2.68 Million
Q3 2022

Oct 13, 2022
SELL
$95.28 - $116.93 $23,820 - $29,232
-250 Reduced 1.26%
19,601 $1.95 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $2,168 - $2,558
-21 Reduced 0.11%
19,851 $2.21 Million
Q1 2022

May 13, 2022
SELL
$93.1 - $112.54 $182,755 - $220,916
-1,963 Reduced 8.99%
19,872 $2.21 Million
Q3 2021

Nov 04, 2021
SELL
$84.42 - $106.62 $67,536 - $85,296
-800 Reduced 3.53%
21,835 $2.1 Million
Q2 2021

Jul 28, 2021
SELL
$67.66 - $84.76 $125,171 - $156,806
-1,850 Reduced 7.56%
22,635 $1.9 Million
Q1 2021

May 05, 2021
SELL
$67.06 - $75.82 $222,303 - $251,343
-3,315 Reduced 11.92%
24,485 $1.65 Million
Q4 2020

Jan 11, 2021
BUY
$63.89 - $73.8 $159,725 - $184,500
2,500 Added 9.88%
27,800 $1.94 Million
Q3 2020

Nov 02, 2020
SELL
$63.69 - $70.22 $159,225 - $175,550
-2,500 Reduced 8.99%
25,300 $1.76 Million
Q1 2020

Apr 16, 2020
SELL
$49.46 - $64.78 $17,953 - $23,515
-363 Reduced 1.29%
27,800 $1.67 Million
Q4 2019

Jan 14, 2020
SELL
$49.86 - $58.26 $21,988 - $25,692
-441 Reduced 1.54%
28,163 $1.63 Million
Q3 2019

Nov 04, 2019
BUY
$47.54 - $53.43 $4,944 - $5,556
104 Added 0.36%
28,604 $1.48 Million
Q2 2019

Aug 12, 2019
SELL
$46.79 - $52.47 $16,657 - $18,679
-356 Reduced 1.23%
28,500 $1.46 Million
Q1 2019

Apr 01, 2019
SELL
$46.36 - $52.63 $53,035 - $60,208
-1,144 Reduced 3.81%
28,856 $1.51 Million
Q4 2018

Feb 08, 2019
SELL
$41.54 - $47.25 $315,205 - $358,533
-7,588 Reduced 20.19%
30,000 $1.38 Million
Q3 2018

Nov 06, 2018
SELL
$46.76 - $51.24 $42,084 - $46,116
-900 Reduced 2.34%
37,588 $1.77 Million
Q2 2018

Aug 07, 2018
SELL
$44.29 - $50.42 $2.08 Million - $2.37 Million
-46,954 Reduced 54.95%
38,488 $1.78 Million
Q1 2018

Apr 30, 2018
SELL
$48.49 - $58.14 $90,821 - $108,896
-1,873 Reduced 2.15%
85,442 $4.21 Million
Q4 2017

Jan 30, 2018
BUY
$47.53 - $53.73 $3.8 Million - $4.29 Million
79,867 Added 1072.33%
87,315 $4.69 Million
Q4 2017

Jan 26, 2018
SELL
$47.53 - $53.73 $3.66 Million - $4.14 Million
-77,065 Reduced 91.19%
7,448 $400,000
Q3 2017

Nov 08, 2017
BUY
$41.15 - $49.22 $3.48 Million - $4.16 Million
84,513
84,513 $4.07 Million

Others Institutions Holding NVO

# of Institutions
1,948
Shares Held
320M
Call Options Held
5.22M
Put Options Held
6.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Donaldson Capital Management, LLC Portfolio

Follow Donaldson Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email